CLX - Clorox Co-The Stock Price, Fair Value and News

147.77USD+1.80 (+1.23%)Market Closed

Market Summary

USD147.77+1.80

Market Closed

1.23%

CLX Stock Price

View Fullscreen

CLX RSI Chart

CLX Valuation

Market Cap

18.1B

Price/Earnings (Trailing)

226.42

Price/Sales (Trailing)

2.48

EV/EBITDA

41.39

Price/Free Cashflow

24.88

CLX Price/Sales (Trailing)

CLX Profitability

EBT Margin

2.15%

Return on Equity

150.94%

Return on Assets

1.35%

Free Cashflow Yield

4.02%

CLX Fundamentals

CLX Revenue

Revenue (TTM)

7.3B

Rev. Growth (Yr)

16.03%

Rev. Growth (Qtr)

43.58%

CLX Earnings

Earnings (TTM)

80.0M

Earnings Growth (Yr)

-6.06%

Earnings Growth (Qtr)

322.73%

Breaking Down CLX Revenue

Last 7 days

2.4%

Last 30 days

-3.2%

Last 90 days

4.5%

Trailing 12 Months

-11.0%

How does CLX drawdown profile look like?

CLX Financial Health

Current Ratio

0.89

Debt/Equity

46.77

Debt/Cashflow

0.38

CLX Investor Care

Dividend Yield

3.12%

Dividend/Share (TTM)

4.72

Shares Dilution (1Y)

0.47%

Diluted EPS (TTM)

0.64

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2023	7.2B	7.4B	7.0B	7.3B
2022	7.1B	7.1B	7.0B	7.1B
2021	7.5B	7.3B	7.2B	7.1B
2020	6.4B	6.7B	7.1B	7.5B
2019	6.3B	6.2B	6.2B	6.1B
2018	6.1B	6.1B	6.2B	6.2B
2017	5.9B	6.0B	6.0B	6.0B
2016	5.7B	5.8B	5.8B	5.9B
2015	5.6B	5.7B	5.7B	5.7B
2014	5.5B	5.5B	5.5B	5.6B
2013	5.5B	5.5B	5.5B	5.5B
2012	5.4B	5.4B	5.4B	5.5B
2011	5.2B	5.2B	5.3B	5.3B
2010	5.3B	5.2B	5.2B	5.2B
2009	5.4B	5.5B	5.4B	5.4B
2008	0	5.3B	5.3B	5.4B

Get all data in R, Python etc through our Historical Stock Data APIs

GRUFITY'S FAIR VALUE MODEL

Stocks Marked 'Very Cheap' by Grufity's Fair Value Model Have Outperformed S&P 500 Index

Grufity's Fair Value model takes all the S&P 500 stocks and divides them into separate buckets based on their attractiveness. The 'Very Cheap' bucket of S&P 500 has greatly outperformed S&P 500 Index. Conversely, S&P500 stocks considered 'Very Expensive' by the model underperformed the S&P500 index in the past three years. Grufity Fair Value is available for 2300+ stocks, including 90% of S&P 500 stocks. Grufity's Fair Value Model separates high-return stocks from low-return stocks.

Returns of $10,000 invested in:

Very Cheap Stocks: $17,289
S&P 500 Index: $12,922
Very Expensive Stocks: $11,022

Grufity's Fair Value model does a great job in separating High Performing Stocks from Low Performing ones in the S&P 500 list.

S&P 500 Index

Very Expensive Stocks

Very Cheap Stocks

Try For Just $1.99

Tracking the Latest Insider Buys and Sells of Clorox Co-The

Filter Transactions

Datesorted ascending	Name	Buy/Sell	$ Value	Avg. Price	# Shares	Title
Mar 28, 2024	williams christopher j	acquired	32,459	153	212	-
Mar 28, 2024	parker paul gray	acquired	13,014	153	85.00	-
Mar 28, 2024	banse amy	acquired	26,181	153	171	-
Mar 14, 2024	hyder chris t	sold (taxes)	-6,369	151	-42.00	group president - health & hyg
Mar 14, 2024	grier stacey	sold (taxes)	-6,369	151	-42.00	evp - executive chief of staff
Dec 29, 2023	parker paul gray	acquired	13,118	142	92.00	-
Dec 14, 2023	hilt angela c	sold (taxes)	-8,672	142	-61.00	evp - chief legal officer
Dec 11, 2023	reynolds eric h	sold (taxes)	-17,221	140	-123	evp - chief operating officer
Dec 11, 2023	jacobsen kevin b	sold (taxes)	-11,900	140	-85.00	evp - chief financial officer
Dec 11, 2023	grier stacey	sold (taxes)	-17,781	140	-127	evp - chief growth & str ofc

Which funds bought or sold CLX recently?

View All Details

Datesorted ascending	Fund Name	Type	% Chg	$ Change	$ Held	% Portfolio
Apr 23, 2024	Canvas Wealth Advisors, LLC	added	15.09	80,635	643,707	0.22%
Apr 23, 2024	Summit Trail Advisors, LLC	new	-	1,439,080	1,439,080	0.04%
Apr 23, 2024	REGIONS FINANCIAL CORP	reduced	-6.9	-458	1,508,290	0.01%
Apr 23, 2024	Total Clarity Wealth Management, Inc.	sold off	-100	-201,315	-	-%
Apr 23, 2024	Venturi Wealth Management, LLC	added	308	22,696	29,398	-%
Apr 23, 2024	ERTS Wealth Advisors, LLC	reduced	-2.55	79,015	1,782,970	0.36%
Apr 23, 2024	Revisor Wealth Management LLC	added	129	356,343	614,517	0.28%
Apr 23, 2024	GODSEY & GIBB, INC	unchanged	-	13,097	190,622	0.02%
Apr 23, 2024	WEDGE CAPITAL MANAGEMENT L L P/NC	added	76.73	1,610,480	3,404,400	0.06%
Apr 23, 2024	WESBANCO BANK INC	added	32.08	200,780	680,881	0.03%

Are Funds Buying or Selling CLX?

Are funds buying CLX calls or puts?

Calls

Puts

No. of funds holding Calls - Puts

Net Call Options

No. of funds that own CLX

No. of Funds

Unveiling Clorox Co-The's Major ShareHolders

Date Filed	Name of Filer	Percent of Class	No. of Shares	Form Type
Feb 13, 2024	vanguard group inc	12.28%	15,228,898	SC 13G/A
Jan 25, 2024	blackrock inc.	8.2%	10,119,551	SC 13G/A
Jan 25, 2024	state street corp	6.78%	8,410,519	SC 13G/A
Feb 09, 2023	vanguard group inc	12.28%	15,151,580	SC 13G/A
Feb 06, 2023	state street corp	7.17%	8,844,196	SC 13G/A
Jan 31, 2023	blackrock inc.	7.5%	9,267,422	SC 13G/A
Feb 14, 2022	state street corp	6.71%	8,240,920	SC 13G/A
Feb 09, 2022	vanguard group inc	11.80%	14,500,034	SC 13G/A
Feb 01, 2022	blackrock inc.	8.8%	10,774,842	SC 13G/A
Feb 12, 2021	state street corp	5.89%	7,426,780	SC 13G

Recent SEC filings of Clorox Co-The

View All Filings

Date Filed	Form Type	Document
Apr 02, 2024	4	Insider Trading
Apr 02, 2024	4	Insider Trading
Apr 02, 2024	4	Insider Trading
Apr 02, 2024	4	Insider Trading
Apr 02, 2024	4	Insider Trading
Apr 02, 2024	4	Insider Trading
Apr 02, 2024	4	Insider Trading
Apr 02, 2024	4	Insider Trading
Mar 25, 2024	4	Insider Trading
Mar 21, 2024	8-K	Current Report

Peers (Alternatives to Clorox Co-The)

Name	Mkt Capsorted ascending	Revenue	Price %, 1M	Returns, 1Y	P/E	P/S	Rev 1-Yr	Inc 1-Yr
LARGE-CAP
PG	381.1B	84.1B	-0.11%	3.28%	25.19	4.53	3.82%	5.63%
CL	72.9B	19.5B	-0.70%	13.74%	31.7	3.75	8.29%	28.85%
EL	53.4B	15.2B	4.01%	-41.28%	110.56	3.52	-7.33%	-68.01%
CHD	26.0B	5.9B	1.99%	16.13%	34.42	4.43	9.16%	82.56%
CLX	18.1B	7.3B	-3.18%	-11.03%	226.42	2.48	3.47%	-81.61%
COTY	10.5B	6.0B	-0.76%	-2.91%	32.32	1.74	14.07%	132.95%
ELF	9.8B	890.1M	-13.82%	86.82%	76.01	11.05	79.24%	176.22%
MID-CAP
IPAR	4.2B	1.3B	-5.54%	-16.25%	27.5	3.19	21.26%	26.23%
NWL	3.0B	8.1B	-6.79%	-40.80%	-7.61	0.36	-14.02%	-296.95%
HIMS	2.6B	872.0M	-24.43%	4.49%	-109.62	2.96	65.49%	64.15%
HELE	2.4B	2.0B	-10.88%	16.86%	14.7	1.19	-7.82%	10.32%
SMALL-CAP
EPC	1.9B	2.3B	0.24%	-14.32%	17.58	0.83	4.31%	6.67%
ACU	147.5M	191.5M	-6.98%	52.19%	8.29	0.77	-1.27%	486.29%
GROV	56.4M	259.3M	-6.36%	244.68%	-1.3	0.22	-19.36%	50.71%
UG	37.4M	10.9M	1.24%	-18.84%	14.49	3.44	-14.28%	0.46%

Clorox Co-The News

Latest updates

Clorox Co-The Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)

(In Millions)

(*) denotes actual numbers (not divided by Millions)
Income Statement (Quarterly)																					(In Millions)
Description	(%) Q/Q	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1	2018Q4
Revenue	43.6%	1,990	1,386	2,019	1,915	1,715	1,740	1,801	1,809	1,691	1,806	1,802	1,781	1,842	1,916	1,983	1,783	1,449	1,506	1,627	1,551	1,473
Gross Profit	62.8%	866	532	862	800	620	626	668	649	558	670	668	774	837	920	929	832	639	663	734	673	643
S&GA Expenses	16.7%	322	276	329	311	282	261	244	233	241	236	260	237	269	238	279	269	210	211	217	216	211
R&D Expenses	10.3%	32.00	29.00	38.00	35.00	33.00	32.00	34.00	31.00	34.00	33.00	45.00	32.00	40.00	32.00	42.00	39.00	34.00	30.00	38.00	34.00	32.00
EBITDA Margin	-2.2%	0.07*	0.07*	0.08*	0.07*	0.13*	0.12*	0.13*	0.13*	0.09*	0.12*	0.16*	0.20*	-	-	-	-	-	-	-	-	-
Interest Expenses	23.8%	26.00	21.00	21.00	24.00	23.00	22.00	37.00	21.00	23.00	25.00	25.00	25.00	24.00	25.00	25.00	24.00	25.00	25.00	25.00	24.00	24.00
Income Taxes	900.0%	40.00	4.00	56.00	-36.00	28.00	29.00	25.00	48.00	21.00	42.00	1.00	-	71.00	109	85.00	56.00	50.00	55.00	51.00	53.00	42.00
Earnings Before Taxes	369.0%	136	29.00	237	-245	130	116	129	200	93.00	185	101	-59.00	332	526	395	297	235	258	292	240	224
EBT Margin	0.1%	0.02*	0.02*	0.03*	0.02*	0.08*	0.08*	0.09*	0.08*	0.05*	0.08*	0.12*	0.16*	-	-	-	-	-	-	-	-	-
Net Income	322.7%	93.00	22.00	176	-211	99.00	85.00	101	150	69.00	142	97.00	-61.00	259	415	310	241	185	203	241	187	182
Net Income Margin	-10.5%	0.01*	0.01*	0.02*	0.01*	0.06*	0.06*	0.07*	0.06*	0.03*	0.06*	0.10*	0.12*	-	-	-	-	-	-	-	-	-
Free Cashflow	2625.0%	101	-4.00	346	285	167	132	256	166	124	-11.00	284	183	-	-	-	-	-	-	-	-	-

Balance Sheet

(In Millions)

(*) denotes actual numbers (not divided by Millions)
Balance Sheet																					(In Millions)
Description	(%) Q/Q	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1	2018Q4
Assets	-1.4%	5,908	5,991	5,945	5,818	6,045	6,153	6,158	6,322	6,190	6,274	6,334	6,441	6,855	6,777	6,213	5,850	5,459	5,397	5,116	5,162	5,073
Current Assets	-5.6%	1,804	1,911	1,828	1,745	1,622	1,763	1,725	1,869	1,741	1,820	1,829	1,962	2,103	2,144	2,020	1,750	1,303	1,266	1,305	1,393	1,365
Cash Equivalents	-31.5%	355	518	367	242	170	280	186	243	196	214	324	497	737	867	879	505	174	157	113	180	165
Inventory	-7.7%	655	710	696	735	741	755	755	803	818	785	752	688	609	534	454	457	514	504	512	556	578
Net PPE	-0.2%	1,314	1,317	1,345	1,315	1,322	1,322	1,334	1,312	1,298	1,301	1,302	1,251	1,221	1,176	1,103	1,047	1,052	1,034	1,034	1,000	992
Goodwill	0.5%	1,252	1,246	1,252	1,250	1,553	1,547	1,558	1,572	1,565	1,566	1,575	1,574	1,803	1,793	208	1,568	1,588	1,585	1,591	1,589	1,586
Liabilities	-2.9%	5,690	5,860	5,557	5,646	5,554	5,657	5,429	5,746	5,699	5,727	5,742	5,503	5,475	5,466	5,305	5,155	4,904	4,847	4,557	4,381	4,331
Current Liabilities	-9.2%	2,022	2,228	1,917	1,996	1,878	2,010	1,784	2,643	2,596	2,639	2,056	1,819	1,738	1,516	1,418	1,794	1,513	1,458	1,440	1,261	1,186
Long Term Debt	0.0%	2,479	2,478	2,477	2,476	2,476	2,475	2,474	1,887	1,886	1,885	2,484	2,483	2,483	2,781	2,780	2,288	2,288	2,287	2,287	2,286	2,285
LT Debt, Current	-	-	-	-	-	-	-	-	600	600	899	300	300	300	-	-	-	-	-	-	-	-
LT Debt, Non Current	0.0%	2,479	2,478	2,477	2,476	2,476	2,475	2,474	1,887	1,886	1,885	2,484	2,483	2,483	2,781	2,780	2,288	2,288	2,287	2,287	2,286	2,285
Shareholder's Equity	-59.5%	53.00	131	220	3.00	491	496	729	576	491	547	592	938	1,380	1,311	908	695	555	550	559	781	742
Retained Earnings	-19.4%	241	299	583	415	782	832	1,048	951	949	1,027	1,036	1,086	1,302	3,840	3,567	3,398	3,292	3,241	3,150	3,004	2,940
Additional Paid-In Capital	-0.1%	1,245	1,246	1,245	1,232	1,207	1,193	1,202	1,195	1,180	1,166	1,186	1,190	1,176	1,146	1,137	1,111	1,062	1,043	1,046	1,033	1,014
Accumulated Depreciation	0.9%	2,792	2,768	2,705	2,672	2,621	2,575	2,530	2,510	2,466	2,422	2,382	2,351	2,319	2,270	2,224	2,203	2,185	2,156	2,150	2,125	2,109
Shares Outstanding	0.1%	124	124	124	124	123	123	123	123	123	123	126	126	-	-	-	-	-	-	-	-	-
Minority Interest	-1.8%	165	168	168	169	170	170	173	176	178	179	181	195	196	196	-	-	-	-	-	-	-
Float	-	-	-	-	-	17,300	-	-	-	21,400	-	-	-	25,300	-	-	-	19,000	-	-	-	19,700

Cashflow (Last 12 Months)

(In Millions)

(*) denotes actual numbers (not divided by Millions)
Cashflow (Quarterly)																					(In Millions)
Description	(%) Q/Q	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1	2018Q4
Cashflow From Operations	665.0%	153	20.00	430	341	209	178	335	229	181	41.00	383	264	246	383	740	308	227	271	389	154	190
Share Based Compensation	23.1%	16.00	13.00	13.00	29.00	21.00	10.00	8.00	19.00	16.00	9.00	-2.00	17.00	22.00	13.00	13.00	18.00	13.00	6.00	9.00	16.00	10.00
Cashflow From Investing	-43.5%	-33.00	-23.00	-81.00	-55.00	-42.00	-45.00	-62.00	-55.00	-56.00	-56.00	-111	-83.00	-107	-151	-107	-47.00	-56.00	-42.00	-70.00	-49.00	-41.00
Cashflow From Financing	-267.1%	-259	155	-227	-211	-280	-35.00	-326	-128	-143	-92.00	-447	-420	-277	-247	-262	77.00	-155	-183	-386	-91.00	-146
Dividend Payments	0%	149	149	146	146	146	145	143	143	143	142	138	140	140	140	134	133	133	133	122	123	123
Buy Backs	-	-	-	-	-	-	-	-	-	-	25.00	300	305	200	100	23.00	30.00	85.00	110	346	72.00	40.00

CLX Income Statement

2023-12-31

Condensed Consolidated Statements of Earnings and Comprehensive Income (Unaudited) - USD ($) shares in Thousands, $ in Millions	3 Months Ended		6 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2023	Dec. 31, 2022
Income Statement [Abstract]
Net sales	$ 1,990	$ 1,715	$ 3,376	$ 3,455
Cost of products sold	1,124	1,095	1,978	2,209
Gross profit	866	620	1,398	1,246
Selling and administrative expenses	322	282	598	543
Advertising costs	186	156	351	317
Research and development costs	32	33	61	65
Pension settlement charge	171	0	171	0
Interest expense	26	23	47	45
Other (income) expense, net	(7)	(4)	5	30
Earnings before income taxes	136	130	165	246
Income tax expense	40	28	44	57
Net earnings	96	102	121	189
Less: Net earnings attributable to noncontrolling interests	3	3	6	5
Net earnings attributable to Clorox	$ 93	$ 99	$ 115	$ 184
Net earnings per share attributable to Clorox
Basic net earnings per share (in dollars per share)	$ 0.75	$ 0.81	$ 0.93	$ 1.49
Diluted net earnings per share (in dollars per share)	$ 0.75	$ 0.80	$ 0.92	$ 1.49
Weighted average shares outstanding (in thousands)
Basic (in shares)	124,176	123,546	124,075	123,443
Diluted (in shares)	124,620	123,988	124,635	123,951
Comprehensive income	$ 231	$ 115	$ 255	$ 166
Less: Total comprehensive income attributable to noncontrolling interests	3	3	6	5
Total comprehensive income attributable to Clorox	$ 228	$ 112	$ 249	$ 161

CLX Balance Sheet

2023-12-31

Condensed Consolidated Balance Sheets - USD ($) $ in Millions	Dec. 31, 2023	Jun. 30, 2023
Current assets
Cash and cash equivalents	$ 355	$ 367
Receivables, net	679	688
Inventories, net	655	696
Prepaid expenses and other current assets	115	77
Total current assets	1,804	1,828
Property, plant and equipment, net of accumulated depreciation and amortization of $2,792 and $2,705, respectively	1,314	1,345
Operating lease right-of-use assets	354	346
Goodwill	1,252	1,252
Trademarks, net	542	543
Other intangible assets, net	156	169
Other assets	486	462
Total assets	5,908	5,945
Current liabilities
Notes and loans payable	247	50
Current operating lease liabilities	92	87
Accounts payable and accrued liabilities	1,649	1,659
Income taxes payable	34	121
Total current liabilities	2,022	1,917
Long-term debt	2,479	2,477
Long-term operating lease liabilities	311	310
Other liabilities	852	825
Deferred income taxes	26	28
Total liabilities	5,690	5,557
Commitments and contingencies
Stockholders’ equity
Preferred stock: $1.00 par value; 5,000,000 shares authorized; none issued or outstanding	0	0
Common stock: $1.00 par value; 750,000,000 shares authorized; 130,741,461 shares issued as of December 31, 2023 and June 30, 2023; and 124,080,634 and 123,820,022 shares outstanding as of December 31, 2023 and June 30, 2023, respectively	131	131
Additional paid-in capital	1,245	1,245
Retained earnings	241	583
Treasury stock, at cost: 6,660,827 and 6,921,439 shares as of December 31, 2023 and June 30, 2023, respectively	(1,205)	(1,246)
Accumulated other comprehensive net (loss) income	(359)	(493)
Total Clorox stockholders’ equity	53	220
Noncontrolling interests	165	168
Total stockholders’ equity	218	388
Total liabilities and stockholders’ equity	$ 5,908	$ 5,945

About Clorox Co-The

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States. The Household segment provides cat litter products under the Fresh Step and Scoop Away brands; bags and wraps under the Glad brand; and grilling products under the Kingsford brand in the United States. The Lifestyle segment offers dressings, dips, seasonings, and sauces primarily under the Hidden Valley brand; natural personal care products under the Burt's Bees brand; and water-filtration products under the Brita brand in the United States. The International segment provides laundry additives; home care products; water-filtration systems; digestive health products; grilling products; cat litter products; food products; bags and wraps; natural personal care products; and professional cleaning and disinfecting products internationally primarily under the Clorox, Ayudin, Clorinda, Poett, Pine-Sol, Glad, Brita, RenewLife, Ever Clean and Burt's Bees brands. It sells its products primarily through mass retailers; grocery outlets; warehouse clubs; dollar stores; home hardware centers; drug, pet, and military stores; third-party and owned e-commerce channels; and distributors, as well as a direct sales force The Clorox Company was founded in 1913 and is headquartered in Oakland, California.

CEO	Ms. Linda Rendle
WEBSITE	thecloroxcompany.com
INDUSTRY	Household Products
EMPLOYEES	8700

Clorox Co-The Frequently Asked Questions

What is the ticker symbol for Clorox Co-The? What does CLX stand for in stocks?

CLX is the stock ticker symbol of Clorox Co-The. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Clorox Co-The (CLX)?

As of Tue Apr 23 2024, market cap of Clorox Co-The is 18.11 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of CLX stock?

You can check CLX's fair value in chart for subscribers.

What is the fair value of CLX stock?

You can check CLX's fair value in chart for subscribers. The fair value of Clorox Co-The is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of Clorox Co-The is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for CLX so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is Clorox Co-The a good stock to buy?

The fair value guage provides a quick view whether CLX is over valued or under valued. Whether Clorox Co-The is cheap or expensive depends on the assumptions which impact Clorox Co-The's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for CLX.

What is Clorox Co-The's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Tue Apr 23 2024, CLX's PE ratio (Price to Earnings) is 226.42 and Price to Sales (PS) ratio is 2.48. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. CLX PE ratio will change depending on the future growth rate expectations of investors.

What is 5 year return on Clorox Co-The's stock?

In the past 10 years, Clorox Co-The has provided 0.073 (multiply by 100 for percentage) rate of return.